Intervention Protocol

You have free access to this content

Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection

  1. Amit Goel*,
  2. Rakesh Aggarwal

Editorial Group: Cochrane Upper GI and Pancreatic Diseases Group

Published Online: 8 OCT 2013

DOI: 10.1002/14651858.CD010776

How to Cite

Goel A, Aggarwal R. Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010776. DOI: 10.1002/14651858.CD010776.

Author Information

  1. Sanjay Gandhi Postgraduate Institute of Medical Sciences, Department of Gastroenterology, Lucknow, Uttar Pradesh, India

*Amit Goel, Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Publication History

  1. Publication Status: New
  2. Published Online: 8 OCT 2013



Additional references

Atherton 2006
Brown 2000
Correa 1992
  • Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Research 1992;52(24):6735-40. [PUBMED: 1458460]
Cremonini 2002
  • Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. American Journal of Gastroenterology 2002;97(11):2744-9. [PUBMED: 12425542]
    Direct Link:
Du 2012
  • Du YQ, Su T, Fan JG, Lu YX, Zheng P, Li XH, et al. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. World Journal of Gastroenterology 2012;18(43):6302-7. [PUBMED: 23180952]
  • EUROGAST study group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993;34(12):1672-6. [PUBMED: 8282253]
Ford 2004
  • Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. American Journal of Gastroenterology 2004;99(9):1833-55. [PUBMED: 15330927]
Fuccio 2009
  • Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?. Annals of Internal Medicine 2009;151(2):121-8. [PUBMED: 19620164]
Higgins 2003
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from
ICH-GCP 1997
  • International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines. Philadelphia: Barnett International / PAREXEL, 1997; Vol. 1:19063-2043.
Malfertheiner 2012
  • Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012;61(5):646-64. [PUBMED: 22491499]
Marshall 1984
Mazzoleni 2011
  • Mazzoleni LE, Sander GB, Francesconi CF, Mazzoleni F, Uchoa DM, De Bona LR, et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Archives of Internal Medicine 2011;171(21):1929-36. [PUBMED: 22123802]
Nista 2004
  • Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Alimentary Pharmacology and Therapeutics 2004;20(10):1181-8. [PUBMED: 15569121]
Ojetti 2012
  • Ojetti V, Bruno G, Ainora ME, Gigante G, Rizzo G, Roccarina D, et al. Impact of Lactobacillus reuteri supplementation on anti-Helicobacter pylori levofloxacin-based second-line therapy. Gastroenterology Research and Practice 2012;740381:1-6. [DOI: 10.1155/2012/740381; PUBMED: 22690211]
RevMan 2012 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Tong 2007
Wang 2013
  • Wang ZH, Gao QY, Fang JY. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. Journal of Clinical Gastroenterology 2013;47(1):25-32. [PUBMED: 23090045]
WHO 1994
  • Anonymous. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer 1994; Vol. 61:1-241. [PUBMED: 7715068]
WHO 2012
  • Anonymous. A review of human carcinogens. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer 2012;100(Pt B):1-441. [PUBMED: 23189750]